Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.56 |
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL17216548 | 1.00 | ALDH1A1 (0.56) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL8011246 | 1.00 | ALDH1A1 (0.56) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL28838063 | 0.98 | ALDH1A1 (0.54) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL17260502 | 0.94 | ALDH1A1 (0.50) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Triphosphate SCHEMBL22659158 | 0.92 | ALDH1A1 (0.52) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Imidazole SCHEMBL29042475 | 0.90 | ALDH1A1 (0.50) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL28404443 | 0.86 | ALDH1A1 (0.42) | ALDH1A1FKBP5FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL1352614 | 0.86 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL1090914 | 0.86 | ALDH1A1 (0.68) | ALDH1A1FKBP5 | |
| Phosphoric Acid SCHEMBL22659156 | 0.86 | ALDH1A1 (0.68) | ALDH1A1FKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115011113-B | Flame-retardant material and preparation method thereof | 江苏集萃先进高分子材料研究所有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-116333020-A | Synthesis method of diquafos sodium | 苏州第四制药厂有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-111040245-A | Pyropolyphosphoric acid imidazole flame retardant and preparation method thereof | 江苏集萃先进高分子材料研究所有限公司 | 2020-04-21 | — | — | CN | claimed |
| EP-4658664-A1 | CAP ANALOGS WITH 5'-TERMINAL ACYCLIC GUANOSINE DERIVATIVE | CureVac SE (DE) | 2025-12-10 | — | — | EP | disclosed |
| US-20250002524-A1 | CAP ANALOGS HAVING AN ACYCLIC LINKER TO THE GUANINE DERIVATIVE NUCLEOBASE | CureVac SE (DE) | 2025-01-02 | — | — | US | disclosed |
| WO-2024160895-A1 | CAP ANALOGS WITH 5'-TERMINAL ACYCLIC GUANOSINE DERIVATIVE | CureVac SE (DE) | 2024-08-08 | — | — | WO | disclosed |
| WO-2023007019-A9 | CAP ANALOGS HAVING AN ACYCLIC LINKER TO THE GUANINE DERIVATIVE NUCLEOBASE | CureVac SE (DE) | 2024-02-29 | — | — | WO | disclosed |
| CN-117362360-A | Preparation method of cap analogue | 星锐医药(苏州)有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-117362360-A | Preparation method of cap analogue | 星锐医药(苏州)有限公司 | 2024-01-09 | — | — | CN | disclosed |
| WO-2023250528-A1 | COMPOSITIONS AND METHODS FOR PREPARING CAPPED CIRCULAR RNA MOLECULES | THE BROAD INSTITUTE, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| CN-115011113-B | Flame-retardant material and preparation method thereof | 江苏集萃先进高分子材料研究所有限公司 | 2023-07-21 | — | — | CN | disclosed |
| WO-2008157688-A2 | SYNTHESIS AND USE OF ANTI-REVERSE PHOSPHOROTHIOATE ANALOGS OF THE MESSENGER RNA CAP | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2008-12-24 | — | — | WO | disclosed |
| CN-1221609-A | Pharmaceutical use of adenosine phosphates and pharmaceutical preparation thereof | KARL Y HOSTETLER (US) | 1999-07-07 | — | — | CN | disclosed |
| CN-1220605-A | Nucleotide analogues for topical treatment of skin cell proliferative disorders | KARL Y HOSTETLER (US) | 1999-06-23 | — | — | CN | disclosed |
| CN-1192138-A | Topical acyclovir derivatives | KARL Y HOSTETLER (US) | 1998-09-02 | — | — | CN | disclosed |
| US-5679785-A | 3'(2')-amino- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides, and a process for the preparation thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-10-21 | — | — | US | disclosed |
| US-5668269-A | 3'-(2')-amimo- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-09-16 | — | — | US | disclosed |
| US-5659025-A | 3'-(2')-amino or thiol-modified, fluorescent dye-coupled oligonucleotides and a process for the preparation and the use thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-08-19 | — | — | US | disclosed |
| EP-0490281-B1 | 3'- Amino or thiolmodified, fluorescence coupled nucleoside and oligonucleotide, a method for their preparation and their use | HOECHST AG (DE) | 1996-09-04 | — | — | EP | disclosed |
| EP-0490281-A1 | 3'- Amino or thiolmodified, fluorescence coupled nucleoside and oligonucleotide, a method for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250002524-A1 | CAP ANALOGS HAVING AN ACYCLIC LINKER TO THE GUANINE DERIVATIVE NUCLEOBASE | RNMT, RNGTT, TRDMT1 | ALDH1A1 3101/4885FKBP5 1389/4885FDPS 1404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.